CINECA IRIS Institutional Research Information System

MOGLIA, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.451
EU - Europa 4.874
AS - Asia 1.833
SA - Sud America 66
OC - Oceania 61
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 11
Totale 13.322
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.330
IT - Italia 1.513
CN - Cina 1.056
IE - Irlanda 735
SE - Svezia 546
AT - Austria 350
FR - Francia 341
DE - Germania 309
KR - Corea 223
FI - Finlandia 221
GB - Regno Unito 202
UA - Ucraina 189
VN - Vietnam 156
JP - Giappone 125
IN - India 107
BE - Belgio 103
CA - Canada 103
PL - Polonia 97
ES - Italia 57
AU - Australia 55
NL - Olanda 51
UZ - Uzbekistan 40
BR - Brasile 34
GR - Grecia 25
TR - Turchia 25
CH - Svizzera 19
RU - Federazione Russa 19
PT - Portogallo 18
HK - Hong Kong 16
IR - Iran 16
MX - Messico 15
IL - Israele 13
AR - Argentina 11
BG - Bulgaria 11
CZ - Repubblica Ceca 11
EU - Europa 11
RO - Romania 10
SG - Singapore 10
TW - Taiwan 10
CO - Colombia 9
BY - Bielorussia 8
CL - Cile 8
DK - Danimarca 8
HU - Ungheria 7
ID - Indonesia 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
SN - Senegal 6
PH - Filippine 5
RS - Serbia 5
ZA - Sudafrica 5
BA - Bosnia-Erzegovina 4
HR - Croazia 4
KZ - Kazakistan 4
NG - Nigeria 4
LK - Sri Lanka 3
MU - Mauritius 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CY - Cipro 2
EC - Ecuador 2
EG - Egitto 2
MT - Malta 2
OM - Oman 2
SA - Arabia Saudita 2
UY - Uruguay 2
CR - Costa Rica 1
CU - Cuba 1
GH - Ghana 1
IM - Isola di Man 1
IQ - Iraq 1
IS - Islanda 1
KE - Kenya 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.322
Salva come PNG Salva come JPEG
Città #
Chandler 1.186
Dublin 721
Beijing 666
Torino 388
Houston 349
Vienna 347
Fairfield 344
Jacksonville 222
Ann Arbor 215
Nyköping 205
Villeurbanne 204
Princeton 201
Medford 193
Wilmington 182
Woodbridge 171
Ashburn 140
Seattle 127
Redwood City 119
Cambridge 117
Dearborn 113
Turin 103
Dong Ket 94
Warsaw 88
Fremont 87
Milan 87
Brussels 82
Pisa 73
Boston 66
Boardman 51
Chengdu 45
Toronto 45
Rome 44
Hangzhou 39
Paris 30
Tokyo 30
Nanjing 28
Washington 26
London 25
Chicago 22
San Diego 22
Cervignano Del Friuli 21
Norwalk 21
Shanghai 21
Falls Church 20
Seoul 19
Shenyang 19
Hefei 18
Mountain View 18
Ottawa 18
Sydney 18
Bologna 15
Hebei 15
Kunming 14
New York 14
Salerno 14
Cagliari 13
Duncan 12
Genova 12
San Mateo 12
Silver Spring 12
Guangzhou 11
Munich 11
Nürnberg 11
Padova 11
Buffalo 10
Detroit 10
Palermo 10
Phoenix 10
Wuhan 10
Athens 9
Nanchang 9
Oxford 9
Upper Marlboro 9
Utrecht 9
Amsterdam 8
Bengaluru 8
Bethesda 8
Delhi 8
Dronten 8
Florence 8
Fuzhou 8
Guiyang 8
Napoli 8
San Mauro Torinese 8
São Paulo 8
Zhengzhou 8
Berlin 7
Buenos Aires 7
Eugene 7
Sanayi 7
Sofia 7
Stockholm 7
Straubing 7
Taipei 7
Atlanta 6
Bari 6
Brisbane 6
Budapest 6
Cascina 6
Chennai 6
Totale 7.950
Salva come PNG Salva come JPEG
Nome #
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 537
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 372
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson’s disease complicated by psychosis or dementia in a Sardinian population 367
The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis 243
Coffee and Amyotrophic Lateral Sclerosis: A Possible Preventive Role 218
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 212
Validation of the revised classification of cognitive and behavioural impairment in ALS 195
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis 185
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. 180
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 172
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 165
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. 162
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 160
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 154
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 148
A longitudinal study on quality of life and depression in ALS patient-caregiver couples 146
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 142
18 F-FDG-PET correlates of cognitive impairment in ALS 141
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 140
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 137
The multistep hypothesis of ALS revisited: The role of genetic mutations 129
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 128
Large Proportion of Amyotrophic Lateral Sclerosis Cases in Sardinia Due to a Single Founder Mutation of the TARDBP Gene 128
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 125
A Strange Loop: Effects of emotional facial expressions impaired recognition in ALS Patients and in their Caregivers. 118
Can eye-tracking system communication improve quality of life and mood in ALS patients with locked-in syndrome 115
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 115
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 113
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 109
Increased cytoplasmic mislocalization of TAR DNA binding protein 43 (TDP-43) in circulating lymphomonocytes of ALS patients recapitulates the major dysfunction featuring motor neurons in the disease. 107
Expression of NOX2 protein in neutrophils of patients with ALS 106
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 103
Quality control of Motor Unit Number Index (MUNIX) measurements in 6 muscles in a single-subject "round-robin" setup 101
Validation of the Italian version of self-administered ALSFRS-R scale 99
Influence of cigarette smoking on ALS outcome: A population-based study 98
Studio longitudinale sulla qualità di vita in pazienti affetti da SLA arruolati e non arruali in clinical trial 97
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls 96
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 96
HFE p.H63D polymorphism does not influence ALS phenotype and survival 94
Cognitive impairment across ALS clinical stages in a population-based cohort 92
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 91
Extensive genetics of ALS: A population-based study in Italy 90
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 90
Factors predicting survival in ALS: a multicenter Italian study 88
Progranulin plasma levels in relation to the expected TDP-43 pathology. 87
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 87
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population 86
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 86
Lithium carbonate does not prevent ALS: a case-report of four patients on long-term therapy for the treatment of bipolar disorder 85
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 85
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 83
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 83
Progranulin plasma levels in patients with and without TDP-43 pathology. 83
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 82
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 81
Amyotrophic lateral sclerosis mimic syndrome due to a dorsal spinal cord neurofibroma 81
Lower serum lipid levels are related to respiratory impairment in patient with ALS 79
A phase I-II multicenter study on G-CSF in ALS: clinical and hematological results 78
Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations 78
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 78
Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation 77
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. 77
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 76
An ALS patient with a Homozygous A382T Missense Mutation of the TARDBP Gene 76
A cluster of ALS Cases in Sardinia due to a founder mutation of the TARDBP gene 76
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 76
EXECUTIVE DYSFUNCTION SCORE OF THE FRONTAL BEHAVIOR SYSTEM SCALE (FrSBe) IS INDEPENDENTLY RELATED TO ALS OUTCOME 74
Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study. 74
Blood lipid levels are related to respiratory function in ALS 71
A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD 71
DETECTING COGNITIVE CHANGES IN ALS: A POPULATION-BASED STUDY 71
Frontotemporal dementia in three cases of familial amyotrophic lateral sclerosis with TARDBP A382T mutation 70
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 70
An ALS-FTD Patient Carrying a Double Pathogenetic Mutation of C9ORF72 and TARDBP: Case Report 67
Weight loss is the best marker of malnutrition in ALS: a prospective study 66
Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene 66
Anxiety undermines quality of life in ALS patients and caregivers 66
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 66
A pilot trial of G-CSF in amyotrophic lateral sclerosis 65
Breaking bad news in ALS from a patients’ and ceregivers’ perspective 65
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study 65
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72 64
Cognitive screening in patients with amyotrophic lateral sclerosis in early stages 63
An ALS case with a novel D90N-SOD1 heterozygous missense mutation 63
Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV 62
Religiosity does not influence quality of life and depression in ALS caregivers 62
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 62
Da SLA a carcinoma dell'orofaringe: un caso clinico 61
Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life 61
A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. 60
ALS phenotype is influenced by age, sex, and genetics: A population-based study 60
Cognitive Reserve in ALS with Comorbid Frontotemporal Dementia (FTD): A Population-Based Study 59
La religiosità non influenza la qualità di vita e la depressione nei caregiver dei pazienti affetti da SLA 58
Genetic architecture of ALS in Sardinia. 58
Reduced cellular Ca(2+) availability enhances TDP-43 cleavage by apoptotic caspases. 58
Monomelic amyotrophy is not always benign: A case report 57
ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations 57
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 57
null 57
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 57
Totale 10.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.804
article - articoli 0
book - libri 0
conference - conferenze 6.656
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019940 0 0 0 61 57 64 74 164 57 111 212 140
2019/20201.658 71 68 65 161 76 290 209 135 183 218 103 79
2020/20211.746 151 118 108 87 157 133 138 133 245 141 83 252
2021/20222.364 83 53 123 199 151 133 126 118 105 250 571 452
2022/20233.794 418 337 102 325 336 873 282 255 398 146 184 138
2023/2024783 268 338 172 5 0 0 0 0 0 0 0 0
Totale 13.817